|
G |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:15,194,633...15,217,836
Ensembl chr 9:15,194,633...15,217,744
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene |
CTD |
PMID:33854195 |
|
NCBI chr12:84,034,635...84,040,651
Ensembl chr12:84,034,635...84,040,647
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:84,084,028...84,091,497
Ensembl chr12:84,085,153...84,095,375
|
|
G |
Acy1 |
aminoacylase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:106,310,180...106,315,594
Ensembl chr 9:106,310,180...106,315,518
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:89,246,947...89,257,589
Ensembl chr 3:89,245,849...89,257,303
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:81,984,612...82,263,658
Ensembl chr 7:81,984,902...82,263,658
|
|
G |
Adcy6 |
adenylate cyclase 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:98,484,982...98,508,119
Ensembl chr15:98,487,854...98,507,957
|
|
G |
Adrm1 |
adhesion regulating molecule 1 26S proteasome ubiquitin receptor |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:179,813,381...179,818,076
Ensembl chr 2:179,813,278...179,818,079
|
|
G |
Afp |
alpha fetoprotein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Aig1 |
androgen-induced 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:13,522,798...13,744,980
Ensembl chr10:13,522,798...13,744,724
|
|
G |
Akap8 |
A kinase anchor protein 8 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:32,522,646...32,540,212
Ensembl chr17:32,522,646...32,540,212
|
|
G |
Akap8l |
A kinase anchor protein 8-like |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:32,540,398...32,569,589
Ensembl chr17:32,540,398...32,569,581
|
|
G |
Alb |
albumin |
decreases expression |
ISO |
Thiabendazole results in decreased expression of ALB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:167,177,560...167,196,100
Ensembl chr 1:167,177,560...167,196,101
|
|
G |
Alg2 |
ALG2 alpha-1,3/1,6-mannosyltransferase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:47,469,833...47,474,367
Ensembl chr 4:47,465,067...47,474,333
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
|
|
G |
Anks3 |
ankyrin repeat and sterile alpha motif domain containing 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:4,759,290...4,783,362
Ensembl chr16:4,759,300...4,782,069
|
|
G |
Anxa11 |
annexin A11 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:25,842,575...25,887,228
Ensembl chr14:25,842,580...25,887,228
|
|
G |
Aplf |
aprataxin and PNKP like factor |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:87,605,407...87,649,244
Ensembl chr 6:87,605,406...87,649,175
|
|
G |
Apof |
apolipoprotein F |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:128,104,568...128,107,119
Ensembl chr10:128,103,866...128,106,022
|
|
G |
Arf2 |
ADP-ribosylation factor 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:103,857,551...103,876,176
Ensembl chr11:103,857,565...103,876,163
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:145,020,679...145,045,566
Ensembl chr 5:145,020,640...145,045,571
|
|
G |
Asb7 |
ankyrin repeat and SOCS box-containing 7 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:66,294,220...66,339,601
Ensembl chr 7:66,294,313...66,339,344
|
|
G |
Ass1 |
argininosuccinate synthetase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
Atosa |
atos homolog A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:74,860,162...74,939,750
Ensembl chr 9:74,860,151...74,939,746
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:95,963,619...95,966,520
Ensembl chr11:95,959,678...95,966,496
|
|
G |
Atp6v0d1 |
ATPase, H+ transporting, lysosomal V0 subunit D1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:106,251,093...106,292,696
Ensembl chr 8:106,251,097...106,292,679
|
|
G |
Bag3 |
BCL2-associated athanogene 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
|
|
G |
Banp |
BTG3 associated nuclear protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:122,674,711...122,755,999
Ensembl chr 8:122,676,489...122,755,997
|
|
G |
Bcl9 |
B cell CLL/lymphoma 9 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:97,110,974...97,205,718
Ensembl chr 3:97,110,978...97,205,233
|
|
G |
Bhlhb9 |
basic helix-loop-helix domain containing, class B9 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:134,742,388...134,791,828
Ensembl chr X:134,698,343...134,791,830
|
|
G |
Bhmt |
betaine-homocysteine methyltransferase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
|
|
G |
C1qc |
complement component 1, q subcomponent, C chain |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:136,617,115...136,620,225
Ensembl chr 4:136,617,115...136,620,376
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:20,784,943...20,844,225
Ensembl chr14:20,784,943...20,844,156
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
|
|
G |
Caps2 |
calcyphosphine 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:111,999,254...112,052,466
Ensembl chr10:111,999,526...112,052,460
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Thiabendazole results in increased activity of CASP3 protein |
CTD |
PMID:26748015 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Thiabendazole results in increased activity of CASP8 protein |
CTD |
PMID:26748015 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Thiabendazole results in increased activity of CASP9 protein |
CTD |
PMID:26748015 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cbs |
cystathionine beta-synthase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:100,805,442...100,833,748
Ensembl chr13:100,806,225...100,833,748
|
|
G |
Ccnl1 |
cyclin L1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:65,853,333...65,869,451
Ensembl chr 3:65,853,572...65,865,670
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
|
|
G |
Cep85 |
centrosomal protein 85 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:133,857,169...133,914,420
Ensembl chr 4:133,857,169...133,914,423
|
|
G |
Cerk |
ceramide kinase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:86,023,302...86,070,537
Ensembl chr15:86,023,329...86,070,342
|
|
G |
Cfb |
complement factor B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
|
|
G |
Cfl1 |
cofilin 1, non-muscle |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:75,768,964...75,773,584
Ensembl chr10:75,768,964...75,773,581
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
|
|
G |
Chmp5 |
charged multivesicular body protein 5 |
affects expression |
ISO |
Thiabendazole affects the expression of CHMP5 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 4:40,948,553...40,965,302
Ensembl chr 4:40,948,407...40,965,303
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:80,001,824...80,008,620
Ensembl chr10:80,001,819...80,008,620
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:4,264,479...4,273,548
Ensembl chr19:4,264,292...4,273,544
|
|
G |
Clu |
clusterin |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
|
|
G |
Cndp2 |
CNDP dipeptidase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:84,685,590...84,703,827
Ensembl chr18:84,685,590...84,703,827
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:84,967,564...85,020,918
Ensembl chr10:84,967,564...85,020,928
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:10,108,194...10,206,996
Ensembl chr 1:10,108,212...10,206,993
|
|
G |
Csrnp1 |
cysteine-serine-rich nuclear protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:119,800,229...119,813,808
Ensembl chr 9:119,800,229...119,813,724
|
|
G |
Cth |
cystathionine gamma lyase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714
|
|
G |
Ctnnal1 |
catenin alpha like 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:56,810,935...56,865,370
Ensembl chr 4:56,810,935...56,865,188
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:121,996,025...122,188,522
Ensembl chr 5:121,994,429...122,188,165
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression |
ISO |
herbimycin inhibits the reaction [Thiabendazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 protein] Thiabendazole results in increased expression of CYP1A1 mRNA; Thiabendazole results in increased expression of CYP1A1 protein |
CTD |
PMID:8900397 PMID:10103034 PMID:11226373 PMID:14987951 PMID:15110098 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions decreases activity increases expression affects metabolic processing |
ISO |
beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] Thiabendazole results in decreased activity of CYP1A2 protein Thiabendazole results in increased expression of CYP1A2 mRNA Thiabendazole results in increased expression of CYP1A2 mRNA; Thiabendazole results in increased expression of CYP1A2 protein |
CTD |
PMID:10936227 PMID:11124226 PMID:12920490 PMID:15110098 PMID:16261361 PMID:18539377 PMID:18570159 More...
|
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
increases expression |
ISO |
Thiabendazole results in increased expression of CYP2B6 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
increases expression |
ISO |
Thiabendazole results in increased expression of CYP2B2 mRNA; Thiabendazole results in increased expression of CYP2B2 protein |
CTD |
PMID:15110098 |
|
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases activity |
ISO |
Thiabendazole results in decreased activity of CYP2C9 protein |
CTD |
PMID:11124226 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
increases expression |
ISO |
Thiabendazole results in increased expression of CYP3A4 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231
|
|
G |
Cyp4f14 |
cytochrome P450, family 4, subfamily f, polypeptide 14 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
|
|
G |
Cytip |
cytohesin 1 interacting protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:58,019,151...58,085,559
Ensembl chr 2:58,019,149...58,085,544
|
|
G |
Dbp |
D site albumin promoter binding protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:45,354,658...45,359,579
Ensembl chr 7:45,354,512...45,359,627
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:3,425,112...3,475,248
Ensembl chr 2:3,425,168...3,465,167
|
|
G |
Ddx20 |
DEAD box helicase 20 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:105,585,586...105,595,104
Ensembl chr 3:105,585,586...105,594,890
|
|
G |
Ddx5 |
DEAD box helicase 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:106,671,181...106,680,011
Ensembl chr11:106,671,181...106,680,011
|
|
G |
Dffb |
DNA fragmentation factor, beta subunit |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:154,048,904...154,059,578
Ensembl chr 4:154,048,906...154,059,583
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:90,125,399...92,098,454
Ensembl chr 7:90,125,880...92,098,455
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:15,587,616...15,597,275
Ensembl chr17:15,587,616...15,597,134
|
|
G |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene |
CTD |
PMID:33854195 |
|
NCBI chr19:25,587,609...25,601,285
Ensembl chr19:25,587,665...25,601,285
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
|
|
G |
Dzip1l |
DAZ interacting protein 1-like |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 9:99,511,448...99,552,128
Ensembl chr 9:99,511,549...99,551,309
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:31,070,729...31,078,623
Ensembl chr 5:31,070,746...31,078,621
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:24,649,712...24,712,093
Ensembl chr10:24,648,304...24,718,721
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene |
CTD |
PMID:33854195 |
|
NCBI chr17:69,382,642...69,596,986
Ensembl chr17:69,382,678...69,596,984
|
|
G |
Epm2aip1 |
EPM2A interacting protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:111,100,913...111,108,161
Ensembl chr 9:111,100,997...111,108,161
|
|
G |
Erf |
Ets2 repressor factor |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:24,941,985...24,950,522
Ensembl chr 7:24,941,986...24,950,186
|
|
G |
Esd |
esterase D/formylglutathione hydrolase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:74,969,591...74,988,205
Ensembl chr14:74,969,737...74,988,205
|
|
G |
Fam135a |
family with sequence similarity 135, member A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:24,049,824...24,139,444
Ensembl chr 1:24,050,174...24,139,422
|
|
G |
Fam177a |
family with sequence similarity 177, member A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene |
CTD |
PMID:33854195 |
|
NCBI chr12:55,171,313...55,188,889
Ensembl chr12:55,171,254...55,188,889
|
|
G |
Fam204a |
family with sequence similarity 204, member A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:60,187,018...60,215,137
Ensembl chr19:60,187,018...60,215,133
|
|
G |
Fam53a |
family with sequence similarity 53, member A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:33,757,695...33,787,007
Ensembl chr 5:33,757,691...33,786,979
|
|
G |
Ficd |
FIC domain containing |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:113,873,821...113,878,670
Ensembl chr 5:113,873,864...113,878,661
|
|
G |
Fkbp4 |
FK506 binding protein 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:128,407,066...128,415,619
Ensembl chr 6:128,406,698...128,415,640
|
|
G |
Fkbp5 |
FK506 binding protein 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:113,158,029...113,547,113
Ensembl chr 2:113,158,081...113,547,112
|
|
G |
Frmd4b |
FERM domain containing 4B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:97,263,828...97,594,618
Ensembl chr 6:97,263,828...97,594,502
|
|
G |
Fzd6 |
frizzled class receptor 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:38,869,673...38,901,587
Ensembl chr15:38,869,429...38,901,583
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
Thiabendazole results in increased expression of GADD45A mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504
|
|
G |
Gatd3a |
glutamine amidotransferase like class 1 domain containing 3A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:77,997,900...78,005,589
Ensembl chr10:77,997,900...78,005,616
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity multiple interactions |
EXP |
Thiabendazole results in increased activity of GCLC protein [Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein |
CTD |
PMID:11019651 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Gin1 |
gypsy retrotransposon integrase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:97,697,894...97,721,435
Ensembl chr 1:97,697,897...97,721,434
|
|
G |
Git2 |
GIT ArfGAP 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:114,865,469...114,912,647
Ensembl chr 5:114,865,468...114,913,578
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
|
|
G |
Gm715 |
predicted gene 715 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:59,591,614...59,592,823
Ensembl chr X:59,591,614...59,592,823
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:69,732,344...69,749,684
Ensembl chr 5:69,730,451...69,749,683
|
|
G |
Gramd1a |
GRAM domain containing 1A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:30,829,552...30,855,374
Ensembl chr 7:30,829,552...30,855,321
|
|
G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene |
CTD |
PMID:33854195 |
|
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
|
|
G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:76,130,917...76,134,109
Ensembl chr15:76,130,964...76,134,104
|
|
G |
Gsdma |
gasdermin A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene |
CTD |
PMID:33854195 |
|
NCBI chr11:98,555,163...98,568,534
Ensembl chr11:98,555,177...98,568,534
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
increases expression |
ISO |
Thiabendazole results in increased expression of GSTP1 mRNA |
CTD |
PMID:15110098 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
increases expression |
ISO |
Thiabendazole results in increased expression of GSTT1 mRNA |
CTD |
PMID:15110098 |
|
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:36,899,581...36,916,258
Ensembl chr18:36,899,581...36,916,258
|
|
G |
Hebp1 |
heme binding protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:135,114,517...135,145,213
Ensembl chr 6:135,114,520...135,175,020
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
|
|
G |
Hs3st3b1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:63,775,519...63,813,110
Ensembl chr11:63,776,618...63,813,116
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766
|
|
G |
Hspa1b |
heat shock protein 1B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspbp1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:4,663,514...4,688,218
Ensembl chr 7:4,663,520...4,688,067
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:128,212,905...128,298,161
Ensembl chr 7:128,213,052...128,298,149
|
|
G |
Iqcb1 |
IQ calmodulin-binding motif containing 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IQCB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:36,648,722...36,694,044
Ensembl chr16:36,648,747...36,693,083
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:127,315,035...127,320,725
Ensembl chr 8:127,315,035...127,320,725
|
|
G |
Itprip |
inositol 1,4,5-triphosphate receptor interacting protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ITPRIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:47,883,029...47,907,738
Ensembl chr19:47,883,041...47,907,738
|
|
G |
Junb |
jun B proto-oncogene |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of JUNB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
|
|
G |
Katnip |
katanin interacting protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KATNIP gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:125,307,027...125,473,967
Ensembl chr 7:125,307,060...125,473,965
|
|
G |
Khdc4 |
KH domain containing 4, pre-mRNA splicing factor |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KHDC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:88,593,087...88,620,240
Ensembl chr 3:88,593,110...88,620,231
|
|
G |
Klf10 |
Kruppel-like transcription factor 10 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KLF10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:38,291,702...38,300,950
Ensembl chr15:38,291,707...38,300,950
|
|
G |
Klf2 |
Kruppel-like transcription factor 2 (lung) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of KLF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:73,072,906...73,075,498
Ensembl chr 8:73,072,877...73,075,500
|
|
G |
Klhl10 |
kelch-like 10 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene |
CTD |
PMID:33854195 |
|
NCBI chr11:100,331,954...100,347,853
Ensembl chr11:100,332,743...100,347,848
|
|
G |
Lgalsl |
galectin like |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:20,773,355...20,781,916
Ensembl chr11:20,773,576...20,781,056
|
|
G |
Lhx2 |
LIM homeobox protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of LHX2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:38,229,282...38,259,747
Ensembl chr 2:38,229,293...38,259,745
|
|
G |
Litaf |
LPS-induced TN factor |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LITAF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:10,777,137...10,810,985
Ensembl chr16:10,777,139...10,884,021
|
|
G |
Lnx2 |
ligand of numb-protein X 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LNX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:146,953,471...147,013,364
Ensembl chr 5:146,953,465...147,013,396
|
|
G |
Loxl3 |
lysyl oxidase-like 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LOXL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:83,011,186...83,029,547
Ensembl chr 6:83,011,154...83,029,543
|
|
G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPCAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr13:73,615,332...73,664,539
Ensembl chr13:73,615,316...73,664,541
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPGAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:191,449,682...191,516,367
Ensembl chr 1:191,449,946...191,516,367
|
|
G |
Lpin3 |
lipin 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LPIN3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:160,722,590...160,747,920
Ensembl chr 2:160,722,590...160,747,922
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LTA4H mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:93,289,258...93,320,758
Ensembl chr10:93,289,273...93,320,737
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LURAP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:80,828,923...80,872,538
Ensembl chr 4:80,828,883...80,873,865
|
|
G |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MAPKAPK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:130,981,437...131,025,580
Ensembl chr 1:130,981,437...131,025,563
|
|
G |
Marf1 |
meiosis regulator and mRNA stability 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MARF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:13,927,030...13,977,157
Ensembl chr16:13,927,037...13,981,215
|
|
G |
Med12l |
mediator complex subunit 12-like |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MED12L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:58,912,820...59,225,867
Ensembl chr 3:58,913,246...59,226,103
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase subunit |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:123,161,944...123,179,639
Ensembl chr 3:123,161,946...123,179,757
|
|
G |
Mfap5 |
microfibrillar associated protein 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of MFAP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:122,490,543...122,506,249
Ensembl chr 6:122,482,804...122,506,249
|
|
G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR122 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
|
|
G |
Mir130a |
microRNA 130a |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR130A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 2:84,571,459...84,571,522
Ensembl chr 2:84,571,459...84,571,522
|
|
G |
Mir146 |
microRNA 146 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR146A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
|
|
G |
Mir22 |
microRNA 22 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR22 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636
|
|
G |
Mir32 |
microRNA 32 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR32 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 4:56,895,229...56,895,298
Ensembl chr 4:56,895,229...56,895,298
|
|
G |
Mir33 |
microRNA 33 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr15:82,082,323...82,082,391
Ensembl chr15:82,082,323...82,082,391
|
|
G |
Mir486 |
microRNA 486 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR486 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 8:23,632,571...23,632,698
Ensembl chr 8:23,632,571...23,632,698
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MLYCD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:120,121,591...120,148,577
Ensembl chr 8:120,121,617...120,137,841
|
|
G |
Mocs2 |
molybdenum cofactor synthesis 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MOCS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:114,954,707...114,965,960
Ensembl chr13:114,954,772...114,968,811
|
|
G |
Morc3 |
microrchidia 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MORC3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:93,629,009...93,672,964
Ensembl chr16:93,629,009...93,672,961
|
|
G |
Mpo |
myeloperoxidase |
increases metabolic processing |
ISO |
MPO protein results in increased metabolism of Thiabendazole metabolite |
CTD |
PMID:21513789 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Mrgbp |
MRG/MORF4L binding protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRGBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:180,222,990...180,228,097
Ensembl chr 2:180,223,097...180,228,097
|
|
G |
Mrnip |
MRN complex interacting protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRNIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:50,065,678...50,090,943
Ensembl chr11:50,065,271...50,090,942
|
|
G |
Mrpl44 |
mitochondrial ribosomal protein L44 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPL44 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:79,753,735...79,759,162
Ensembl chr 1:79,753,735...79,759,162
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:36,221,272...36,227,332
Ensembl chr17:36,221,271...36,227,281
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MTARC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:184,518,964...184,543,622
Ensembl chr 1:184,518,964...184,543,394
|
|
G |
Myo10 |
myosin X |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:25,622,636...25,813,759
Ensembl chr15:25,622,611...25,813,759
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of N4BP2L2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:150,515,310...150,589,213
Ensembl chr 5:150,531,472...150,589,648
|
|
G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NAE1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:105,237,660...105,261,269
Ensembl chr 8:105,237,660...105,261,269
|
|
G |
Ndufb11 |
NADH:ubiquinone oxidoreductase subunit B11 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of NDUFB11 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:20,481,565...20,483,858
Ensembl chr X:20,481,565...20,483,858
|
|
G |
Nfe2 |
nuclear factor, erythroid derived 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NFE2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:103,156,640...103,166,809
Ensembl chr15:103,156,639...103,166,830
|
|
G |
Nfil3 |
nuclear factor, interleukin 3, regulated |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NFIL3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109
|
|
G |
Nppb |
natriuretic peptide type B |
increases expression |
ISO |
Thiabendazole results in increased expression of NPPB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR0B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Thiabendazole results in increased activity of NR1I2 protein |
CTD |
PMID:25455453 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NUCKS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:131,838,196...131,864,059
Ensembl chr 1:131,838,272...131,864,059
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:76,180,803...76,215,381
Ensembl chr15:76,180,801...76,212,215
|
|
G |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:127,368,987...127,374,322
Ensembl chr 7:127,368,987...127,374,322
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
affects expression |
ISO |
Thiabendazole affects the expression of OXCT1 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr15:4,055,910...4,184,826
Ensembl chr15:4,055,865...4,184,826
|
|
G |
Pabir1 |
PP2A A alpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PABIR1 gene |
CTD |
PMID:33854195 |
|
NCBI chr19:24,451,270...24,454,819
Ensembl chr19:24,453,866...24,454,720
|
|
G |
Parpbp |
PARP1 binding protein |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of PARPBP gene |
CTD |
PMID:33854195 |
|
NCBI chr10:87,927,260...87,982,831
Ensembl chr10:87,927,294...87,982,803
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 (elfin) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:40,210,683...40,260,060
Ensembl chr19:40,209,617...40,260,286
|
|
G |
Pdp1 |
pyruvate dehydrogenase phosphatase catalytic subunit 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:11,958,183...11,966,450
Ensembl chr 4:11,958,184...11,966,452
|
|
G |
Pdzd2 |
PDZ domain containing 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene |
CTD |
PMID:33854195 |
|
NCBI chr15:12,359,797...12,740,052
Ensembl chr15:12,359,797...12,740,010
|
|
G |
Per1 |
period circadian clock 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PER1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786
|
|
G |
Per3 |
period circadian clock 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:151,081,475...151,129,167
Ensembl chr 4:151,088,109...151,129,122
|
|
G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
increases expression |
ISO |
Thiabendazole results in increased expression of PFKFB1 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr X:149,370,441...149,426,874
Ensembl chr X:149,371,225...149,426,874
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PGK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305
|
|
G |
Pias3 |
protein inhibitor of activated STAT 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIAS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:96,603,679...96,613,386
Ensembl chr 3:96,603,700...96,613,386
|
|
G |
Pip4p1 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIP4P1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:51,164,672...51,168,306
Ensembl chr14:51,163,525...51,168,313
|
|
G |
Pirb |
paired Ig-like receptor B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LILRB3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:3,715,504...3,723,381
Ensembl chr 7:3,714,408...3,723,390
|
|
G |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:152,156,890...152,199,855
Ensembl chr 4:152,156,955...152,199,857
|
|
G |
Plk2 |
polo like kinase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:110,531,578...110,537,378
Ensembl chr13:110,531,580...110,537,378
|
|
G |
Plpp4 |
phospholipid phosphatase 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PLPP4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:128,858,114...128,993,138
Ensembl chr 7:128,858,755...128,993,136
|
|
G |
Pmvk |
phosphomevalonate kinase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PMVK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:89,361,848...89,376,321
Ensembl chr 3:89,361,848...89,376,320
|
|
G |
Pnkd |
paroxysmal nonkinesiogenic dyskinesia |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNKD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:74,323,757...74,392,851
Ensembl chr 1:74,324,089...74,392,853
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNRC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of POR gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
|
|
G |
Prdm15 |
PR domain containing 15 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRDM15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:97,592,720...97,653,076
Ensembl chr16:97,592,667...97,653,050
|
|
G |
Prelid2 |
PRELI domain containing 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELID2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:42,008,761...42,084,259
Ensembl chr18:42,008,665...42,084,307
|
|
G |
Prelp |
proline arginine-rich end leucine-rich repeat |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:133,838,042...133,857,820
Ensembl chr 1:133,838,042...133,849,152
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
Thiabendazole results in increased expression of PRKCB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
|
|
G |
Proser2 |
proline and serine rich 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PROSER2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:6,103,304...6,135,100
Ensembl chr 2:6,102,418...6,135,022
|
|
G |
Prpf39 |
pre-mRNA processing factor 39 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRPF39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:65,083,094...65,110,160
Ensembl chr12:65,083,107...65,110,160
|
|
G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:21,990,273...22,008,785
Ensembl chr 5:21,990,281...22,008,785
|
|
G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:27,741,127...27,749,517
Ensembl chr 7:27,741,132...27,749,526
|
|
G |
Psmc5 |
protease (prosome, macropain) 26S subunit, ATPase 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:106,147,011...106,153,938
Ensembl chr11:106,146,980...106,153,946
|
|
G |
Ptpa |
protein phosphatase 2 protein activator |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PTPA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:30,306,062...30,337,819
Ensembl chr 2:30,306,051...30,337,818
|
|
G |
Pus10 |
pseudouridylate synthase 10 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PUS10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:23,608,588...23,682,876
Ensembl chr11:23,615,674...23,682,876
|
|
G |
Rabep1 |
rabaptin, RAB GTPase binding effector protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABEP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:70,735,553...70,833,931
Ensembl chr11:70,735,604...70,833,931
|
|
G |
Rabl2 |
RAB, member RAS oncogene family-like 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABL2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:89,466,730...89,476,126
Ensembl chr15:89,466,736...89,476,126
|
|
G |
Ramac |
RNA guanine-7 methyltransferase activating subunit |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RAMAC gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:81,412,701...81,419,238
Ensembl chr 7:81,412,673...81,419,239
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RANGAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:81,588,449...81,614,120
Ensembl chr15:81,588,449...81,629,731
|
|
G |
Rars1 |
arginyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:35,699,207...35,725,355
Ensembl chr11:35,699,208...35,725,333
|
|
G |
Rbm14 |
RNA binding motif protein 14 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RBM14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:4,850,594...4,861,662
Ensembl chr19:4,850,597...4,861,662
|
|
G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RBM3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:8,005,214...8,012,119
Ensembl chr X:8,005,214...8,012,119
|
|
G |
Rbpms |
RNA binding protein gene with multiple splicing |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RBPMS gene |
CTD |
PMID:33854195 |
|
NCBI chr 8:34,272,671...34,419,925
Ensembl chr 8:34,272,671...34,419,891
|
|
G |
Resf1 |
retroelement silencing factor 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:149,210,907...149,237,161
Ensembl chr 6:149,210,912...149,237,161
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of REV1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:38,091,867...38,169,191
Ensembl chr 1:38,091,867...38,168,882
|
|
G |
Rfx7 |
regulatory factor X, 7 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RFX7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:72,439,346...72,530,231
Ensembl chr 9:72,439,522...72,530,111
|
|
G |
Rgcc |
regulator of cell cycle |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RGCC gene |
CTD |
PMID:33854195 |
|
NCBI chr14:79,526,190...79,539,075
Ensembl chr14:79,526,196...79,539,085
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RGS16 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:153,616,099...153,621,212
Ensembl chr 1:153,616,095...153,621,214
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:76,017,656...76,092,054
Ensembl chr13:76,017,656...76,092,044
|
|
G |
Rnase10 |
ribonuclease, RNase A family, 10 (non-active) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RNASE10 gene |
CTD |
PMID:33854195 |
|
NCBI chr14:51,245,208...51,248,218
Ensembl chr14:51,245,208...51,248,215
|
|
G |
Rnd3 |
Rho family GTPase 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RND3 gene; [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RND3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
|
|
G |
Rorc |
RAR-related orphan receptor gamma |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RORC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
|
|
G |
Rxylt1 |
ribitol xylosyltransferase 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RXYLT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:121,916,844...121,933,271
Ensembl chr10:121,914,019...121,933,276
|
|
G |
Sall4 |
spalt like transcription factor 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SALL4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:168,590,252...168,609,121
Ensembl chr 2:168,590,252...168,609,863
|
|
G |
Sardh |
sarcosine dehydrogenase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SARDH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:27,078,405...27,138,344
Ensembl chr 2:27,078,405...27,138,349
|
|
G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SCNN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:125,286,657...125,321,906
Ensembl chr 6:125,297,622...125,321,906
|
|
G |
Sdr42e1 |
short chain dehydrogenase/reductase family 42E, member 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SDR42E1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:118,388,138...118,400,428
Ensembl chr 8:118,388,138...118,400,428
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SESN2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
|
|
G |
Setd6 |
SET domain containing 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SETD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:96,442,211...96,448,135
Ensembl chr 8:96,442,509...96,445,638
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623
|
|
G |
Sh3bp2 |
SH3-domain binding protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:34,683,128...34,720,983
Ensembl chr 5:34,683,182...34,720,985
|
|
G |
Sigirr |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SIGIRR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:140,671,088...140,680,493
Ensembl chr 7:140,671,088...140,680,485
|
|
G |
Sik2 |
salt inducible kinase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SIK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:50,800,944...50,920,432
Ensembl chr 9:50,804,101...50,920,373
|
|
G |
Slc12a6 |
solute carrier family 12, member 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC12A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:112,096,659...112,193,508
Ensembl chr 2:112,096,170...112,193,508
|
|
G |
Slc20a1 |
solute carrier family 20, member 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC20A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:129,038,662...129,053,535
Ensembl chr 2:129,040,684...129,053,536
|
|
G |
Slc25a39 |
solute carrier family 25, member 39 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC25A39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:102,293,795...102,299,501
Ensembl chr11:102,293,811...102,298,772
|
|
G |
Slc26a6 |
solute carrier family 26, member 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC26A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:108,731,239...108,742,117
Ensembl chr 9:108,730,482...108,742,117
|
|
G |
Slc37a2 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:37,140,445...37,166,709
Ensembl chr 9:37,138,881...37,167,034
|
|
G |
Slk |
STE20-like kinase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SLK gene |
CTD |
PMID:33854195 |
|
NCBI chr19:47,568,458...47,633,685
Ensembl chr19:47,568,117...47,633,685
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SMAD7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006
|
|
G |
Smpx |
small muscle protein, X-linked |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SMPX gene |
CTD |
PMID:33854195 |
|
NCBI chr X:156,481,969...156,535,587
Ensembl chr X:156,481,906...156,535,587
|
|
G |
Snrnp200 |
small nuclear ribonucleoprotein 200 (U5) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SNRNP200 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:127,050,306...127,082,373
Ensembl chr 2:127,050,306...127,082,371
|
|
G |
Snx4 |
sorting nexin 4 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SNX4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:33,071,826...33,119,932
Ensembl chr16:33,071,812...33,120,639
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SOCS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
|
|
G |
Sod3 |
superoxide dismutase 3, extracellular |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SOD3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
|
|
G |
Sohlh1 |
spermatogenesis and oogenesis specific basic helix-loop-helix 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SOHLH1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:25,733,007...25,737,347
Ensembl chr 2:25,733,007...25,737,260
|
|
G |
Spag1 |
sperm associated antigen 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SPAG1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:36,175,629...36,235,767
Ensembl chr15:36,178,245...36,235,767
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene |
CTD |
PMID:33854195 |
|
NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911
|
|
G |
Srrm2 |
serine/arginine repetitive matrix 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:24,009,501...24,043,715
Ensembl chr17:24,009,506...24,043,715
|
|
G |
Srsf5 |
serine and arginine-rich splicing factor 5 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRSF5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:80,992,308...80,997,277
Ensembl chr12:80,992,278...80,997,281
|
|
G |
Stard9 |
StAR related lipid transfer domain containing 9 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of STARD9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:120,459,567...120,562,371
Ensembl chr 2:120,459,602...120,562,376
|
|
G |
Susd2 |
sushi domain containing 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SUSD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:75,472,453...75,479,842
Ensembl chr10:75,472,540...75,479,842
|
|
G |
Sympk |
symplekin |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SYMPK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:18,758,321...18,788,542
Ensembl chr 7:18,758,302...18,788,543
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9B |
affects expression |
ISO |
Thiabendazole affects the expression of TAF9B mRNA |
CTD |
PMID:18539377 |
|
NCBI chr X:105,250,480...105,264,764
Ensembl chr X:105,250,489...105,264,764
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TAT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435
|
|
G |
Tdp2 |
tyrosyl-DNA phosphodiesterase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:25,015,642...25,026,136
Ensembl chr13:25,015,662...25,026,136
|
|
G |
Tead2 |
TEA domain family member 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TEAD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:44,865,216...44,882,892
Ensembl chr 7:44,865,177...44,883,068
|
|
G |
Tecr |
trans-2,3-enoyl-CoA reductase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TECR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:84,298,327...84,321,120
Ensembl chr 8:84,298,327...84,334,600
|
|
G |
Tgds |
TDP-glucose 4,6-dehydratase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:118,349,323...118,370,177
Ensembl chr14:118,349,323...118,370,167
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TGFBI mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:56,757,399...56,787,172
Ensembl chr13:56,757,336...56,787,375
|
|
G |
Tjap1 |
tight junction associated protein 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TJAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:46,568,777...46,593,991
Ensembl chr17:46,568,777...46,593,952
|
|
G |
Tkt |
transketolase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TKT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMBIM6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:99,290,828...99,307,930
Ensembl chr15:99,290,763...99,307,930
|
|
G |
Tmem268 |
transmembrane protein 268 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:63,472,410...63,504,594
Ensembl chr 4:63,477,018...63,504,594
|
|
G |
Tmt1b |
thiol methyltransferase 1B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:128,794,146...128,796,857
Ensembl chr10:128,794,143...128,796,857
|
|
G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:111,408,898...111,421,452
Ensembl chr12:111,408,903...111,421,452
|
|
G |
Tor3a |
torsin family 3, member A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TOR3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:156,481,187...156,501,909
Ensembl chr 1:156,481,187...156,501,926
|
|
G |
Traf3ip2 |
TRAF3 interacting protein 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:39,488,930...39,531,303
Ensembl chr10:39,488,930...39,531,303
|
|
G |
Trafd1 |
TRAF type zinc finger domain containing 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAFD1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:121,509,788...121,524,543
Ensembl chr 5:121,509,788...121,523,695
|
|
G |
Trim3 |
tripartite motif-containing 3 |
increases expression |
ISO |
Thiabendazole results in increased expression of TRIM3 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 7:105,253,670...105,282,805
Ensembl chr 7:105,253,670...105,282,778
|
|
G |
Trim34a |
tripartite motif-containing 34A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRIM34 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:103,893,657...103,911,446
Ensembl chr 7:103,893,664...103,911,441
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression |
ISO |
Thiabendazole results in increased expression of TP53 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TSC22D3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:139,440,277...139,501,257
Ensembl chr X:139,440,277...139,501,408
|
|
G |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UBA3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:97,160,593...97,182,608
Ensembl chr 6:97,160,631...97,182,608
|
|
G |
Ubb |
ubiquitin B |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:62,442,329...62,444,037
Ensembl chr11:62,441,997...62,444,039
|
|
G |
Ubc |
ubiquitin C |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:125,463,029...125,467,081
Ensembl chr 5:125,463,029...125,467,266
|
|
G |
Uckl1 |
uridine-cytidine kinase 1-like 1 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UCKL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:181,210,942...181,223,820
Ensembl chr 2:181,210,942...181,226,685
|
|
G |
Ugdh |
UDP-glucose dehydrogenase |
increases expression |
ISO |
Thiabendazole results in increased expression of UGDH mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 5:65,570,550...65,593,185
Ensembl chr 5:65,570,564...65,593,292
|
|
G |
Unc45a |
unc-45 myosin chaperone A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:79,975,040...79,990,748
Ensembl chr 7:79,975,040...79,997,741
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:43,978,318...44,006,924
Ensembl chr 9:43,978,318...44,006,924
|
|
G |
Usp40 |
ubiquitin specific peptidase 40 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of USP40 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:87,872,841...87,936,308
Ensembl chr 1:87,872,841...87,936,273
|
|
G |
Utrn |
utrophin |
increases expression |
ISO |
Thiabendazole results in increased expression of UTRN mRNA |
CTD |
PMID:22028826 |
|
NCBI chr10:12,257,931...12,745,632
Ensembl chr10:12,257,932...12,745,109
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of VEGFA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Vnn3 |
vanin 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VNN3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:23,727,360...23,745,741
Ensembl chr10:23,727,360...23,745,741
|
|
G |
Vtn |
vitronectin |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VTN mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:78,389,946...78,393,151
Ensembl chr11:78,389,917...78,393,150
|
|
G |
Wdr11 |
WD repeat domain 11 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of WDR11 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:129,193,373...129,237,462
Ensembl chr 7:129,193,587...129,237,462
|
|
G |
Wee1 |
WEE 1 homolog 1 (S. pombe) |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of WEE1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:109,721,266...109,742,506
Ensembl chr 7:109,721,253...109,742,493
|
|
G |
Wfdc9 |
WAP four-disulfide core domain 9 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:164,491,547...164,499,263
Ensembl chr 2:164,491,551...164,498,503
|
|
G |
Yod1 |
YOD1 deubiquitinase |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:130,645,064...130,652,093
Ensembl chr 1:130,645,064...130,652,095
|
|
G |
Zfc3h1 |
zinc finger, C3H1-type containing |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFC3H1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:115,220,691...115,268,677
Ensembl chr10:115,220,864...115,268,677
|
|
G |
Zfp280d |
zinc finger protein 280D |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP280D mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:72,181,900...72,271,061
Ensembl chr 9:72,182,142...72,271,059
|
|
G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375
|
|
G |
Zfp422 |
zinc finger protein 422 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP422 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:116,600,977...116,605,960
Ensembl chr 6:116,600,977...116,605,960
|
|
G |
Zfp598 |
zinc finger protein 598 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:24,888,661...24,900,997
Ensembl chr17:24,888,661...24,900,990
|
|
G |
Zmym3 |
zinc finger, MYM-type 3 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:100,447,990...100,464,986
Ensembl chr X:100,447,990...100,464,455
|
|
G |
Zmym6 |
zinc finger, MYM-type 6 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:126,971,176...127,018,167
Ensembl chr 4:126,971,176...127,018,165
|
|
G |
Zranb2 |
zinc finger, RAN-binding domain containing 2 |
multiple interactions |
ISO |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZRANB2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:157,239,749...157,254,029
Ensembl chr 3:157,239,797...157,254,047
|
|